FDA-Inspected Site

Southern California Reproductive Center Medical Group PC

5 FDA inspections are on record for Southern California Reproductive Center Medical Group PC in Beverly Hills, United States.

483· Form 483 issued

Beverly Hills, United States · Last updated July 10, 2026

Overview

  • 5 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-07-08.

At a glance

Inspections

5

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
7 Jul 2025 – 8 Jul 2025Biologics483View 483 →
9 Aug 2022 – 15 Aug 2022BiologicsClean
23 Aug 2017 – 24 Aug 2017BiologicsClean
6 Nov 2014BiologicsClean
17 Jun 2011Not recorded483View 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

8 Jul 2025
21 CFR 1271.50(a)

Determination based on screening and testing

Cited by Celeta S Coves, Maurine Fadlalla

17 Jun 2011
21 CFR 1271.47(a)

Procedures for all other requirements

Cited by Diana L Ayala

17 Jun 2011
21 CFR 1271.50(a)

Determination based on screening and testing

Cited by Diana L Ayala

17 Jun 2011
21 CFR 1271.50(a)

Responsible person to determine, document

Cited by Diana L Ayala

17 Jun 2011
21 CFR 1271.75(d)

Donors with risks not determined ineligible

Cited by Diana L Ayala

Investigators

FDA investigators tied to this site in the record.

Celeta S Coves1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 1271.50(a)Cited across public-safe Form 483 observations3x
21 CFR 1271.47(a)Cited across public-safe Form 483 observations1x
21 CFR 1271.75(d)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind this site's 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat